Safety and early efficacy in an ongoing pilot study of brentuximab vedotin and AVD chemotherapy followed by 30 gray involved-site radiotherapy for newly diagnosed, early stage, unfavorable risk Hodgkin lymphoma Meeting Abstract


Authors: Kumar, A.; Yahalom, J.; Schoder, H.; Caron, P.; Drullinsky, P.; Gerecitano, J. F.; Hamilton, A.; Hamlin, P.; Horwitz, S. M.; Jacob, A. G.; Matasar, M. J.; Mccall, S.; Moskowitz, A. J.; Noy, A.; Palomba, L.; Portlock, C. S.; Straus, D. J.; Verwys, S.; Zelenetz, A. D.; Zhang, Z. G.; Younes, A.; Moskowitz, C. H.
Abstract Title: Safety and early efficacy in an ongoing pilot study of brentuximab vedotin and AVD chemotherapy followed by 30 gray involved-site radiotherapy for newly diagnosed, early stage, unfavorable risk Hodgkin lymphoma
Meeting Title: 56th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 124
Issue: 21
Meeting Dates: 2014 Dec 6-9
Meeting Location: San Francisco, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2014-12-06
Language: English
ACCESSION: WOS:000349243501070
PROVIDER: wos
Notes: Meeting Abstract: 3085 -- 56th Annual Meeting of the American-Society-of-Hematology -- DEC 06-09, 2014 -- San Francisco, CA -- Source: Wos
MSK Authors
  1. Zhigang Zhang
    240 Zhang
  2. Joachim Yahalom
    395 Yahalom
  3. Carol Portlock
    178 Portlock
  4. Craig Moskowitz
    372 Moskowitz
  5. Ariela Noy
    205 Noy
  6. Maria Lia Palomba
    121 Palomba
  7. Steven M Horwitz
    351 Horwitz
  8. Heiko Schoder
    285 Schoder
  9. Andrew D Zelenetz
    550 Zelenetz
  10. Alison Moskowitz
    141 Moskowitz
  11. Paul Hamlin
    170 Hamlin
  12. Matthew J Matasar
    119 Matasar
  13. Philip C Caron
    30 Caron
  14. David J Straus
    205 Straus
  15. Susan J McCall
    14 McCall
  16. Anita Kumar
    51 Kumar
  17. Alexandra G Jacob
    7 Jacob
  18. Anas Younes
    195 Younes
  19. Stephanie Lisl Verwys
    4 Verwys
Related MSK Work